CompletedNot Applicable

Evaluation of a Finger Prick Collection Method for Measuring Alzheimer's Disease Blood Biomarkers

United States49 participantsStarted 2025-09-29

Plain-language summary

This is an observational study that will collect blood from a finger prick (Capitainer SEP10 single channel device) and assess the accuracy of pTau-217 testing in comparison to previously collected venous blood samples from the same individuals.

Who can participate

Age range

50 Years – 80 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Able and willing to provide informed consent for the eDROP-AD study. * Enrolled in the Draw-10 study at Banner Alzheimer's Institute-Phoenix and provided at least one venous blood sample. * Able and willing to fully comply with study procedures defined in this protocol. * Written and spoken fluency in the English language. Exclusion Criteria: \-

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Assess the accuracy of within-participant plasma pTau-217 testing on separated blood collected via finger prick with the Capitainer SEP10 single channel device in comparison to venipuncture-based collected samples.

Timeframe: Day 1

Characterize the feasibility of finger prick blood collection with the Capitainer SEP10 single channel device.

Timeframe: Day 1

Characterize the tolerability of finger prick blood collection with the Capitainer SEP10 single channel device.

Timeframe: Day 1

Characterize the acceptability of finger prick blood collection with the Capitainer SEP10 single channel device.

Timeframe: Day 1

Trial details

NCT IDNCT07187921

SponsorBanner Health

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-11-12

View on ClinicalTrials.gov More Alzheimer Disease trials

Who can participate

Age range

50 Years – 80 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Timeframe: Day 1

Characterize the feasibility of finger prick blood collection with the Capitainer SEP10 single channel device.

Timeframe: Day 1

Characterize the tolerability of finger prick blood collection with the Capitainer SEP10 single channel device.

Timeframe: Day 1

Characterize the acceptability of finger prick blood collection with the Capitainer SEP10 single channel device.

Timeframe: Day 1